Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 8,140 | 7,623 | 9,106 | 7,361 | 10,179 |
| Operating Income | -8,140 | -7,623 | -9,106 | -7,361 | -10,179 |
| Interest Expense | 1,150 | 2,145 | 931 | 1,096 | 1,215 |
| Other Income | 281 | 334 | 378 | 504 | 667 |
| Pre-tax Income | -9,009 | -9,434 | -9,659 | -7,952 | -10,727 |
| Income Tax | N/A | N/A | -1,170 | N/A | N/A |
| Net Income Continuous | -9,009 | -9,434 | -8,489 | -7,952 | -10,727 |
| Net Income | $-9,009 | $-9,434 | $-8,489 | $-7,952 | $-10,727 |
| EPS Basic Total Ops | -0.19 | -0.21 | -0.21 | -0.21 | -0.29 |
| EPS Basic Continuous Ops | -0.19 | -0.21 | -0.21 | -0.21 | -0.29 |
| EPS Diluted Total Ops | -0.19 | -0.21 | -0.21 | -0.21 | -0.29 |
| EPS Diluted Continuous Ops | -0.19 | -0.21 | -0.21 | -0.21 | -0.29 |
| EPS Diluted Before Non-Recurring Items | -0.19 | -0.21 | -0.21 | -0.21 | -0.29 |
| EBITDA(a) | $-8,432 | $-6,494 | $-8,818 | $-7,048 | $-9,858 |